SEC Form 4 · accession 0001104659-15-075317
EPIRUS Biopharmaceuticals, Inc. · EPRS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas A. Shea
Officer — Chief Financial Officer
Period of report
Nov 3, 2015
Accepted (ET)
Nov 3, 2015 · 4:37 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001135906
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 3, 2015 | M | 28,926 | $1.30 | A | 28,926 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1,F2 | $1.30 | Nov 3, 2015 | M | 28,926 | D | — | Jul 8, 2023 | Common Stock | 28,926 | 20,662 | D |
Explanation of responses
- F1The option became exercisable with respect to 25% of the shares on June 3, 2014 and with respect to the remaining shares in substantially equal monthly installments over the remaining 3 years.
- F2Expiration date corrected from previously reported date of 07/07/2023 to 07/08/2023.